Cholesterol, LDL

"Cholesterol, LDL" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol.

Descriptor ID	D008078
MeSH Number(s)	D04.210.500.247.808.197.244 D10.532.515.500 D10.570.938.208.275 D12.776.521.550.500
Concept/Terms	Cholesterol, LDL Cholesterol, LDL Low Density Lipoprotein Cholesterol beta-Lipoprotein Cholesterol Cholesterol, beta-Lipoprotein beta Lipoprotein Cholesterol LDL Cholesterol Cholesteryl Linoleate, LDL Cholesteryl Linoleate, LDL LDL Cholesteryl Linoleate

Below are MeSH descriptors whose meaning is more general than "Cholesterol, LDL".

Chemicals and Drugs [D]
Polycyclic Compounds [D04]
Fused-Ring Compounds [D04.210]
Steroids [D04.210.500]
Cholestanes [D04.210.500.247]
Sterols [D04.210.500.247.808]
Cholesterol [D04.210.500.247.808.197]
Cholesterol, LDL [D04.210.500.247.808.197.244]
Lipids [D10]
Lipoproteins [D10.532]
Lipoproteins, LDL [D10.532.515]
Cholesterol, LDL [D10.532.515.500]
Membrane Lipids [D10.570]
Sterols [D10.570.938]
Cholesterol [D10.570.938.208]
Cholesterol, LDL [D10.570.938.208.275]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Lipoproteins [D12.776.521]
Lipoproteins, LDL [D12.776.521.550]
Cholesterol, LDL [D12.776.521.550.500]

Below are MeSH descriptors whose meaning is related to "Cholesterol, LDL".

Below are MeSH descriptors whose meaning is more specific than "Cholesterol, LDL".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cholesterol, LDL" by people in this website by year, and whether "Cholesterol, LDL" was a major or minor topic of these publications.

Bar chart showing 94 publications over 20 distinct years, with a maximum of 8 publications in 2003 and 2006 and 2008 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	0	1	1
2002	2	5	7
2003	2	6	8
2004	3	4	7
2005	1	5	6
2006	1	7	8
2007	0	3	3
2008	3	5	8
2009	1	0	1
2010	0	1	1
2011	1	5	6
2012	1	0	1
2013	3	4	7
2014	2	5	7
2015	0	1	1
2017	3	1	4
2018	1	1	2
2020	4	2	6
2021	1	1	2
2022	0	8	8

Below are the most recent publications written about "Cholesterol, LDL" by people in Profiles.

Laffin LJ, Bruemmer D, Garcia M, Brennan DM, McErlean E, Jacoby DS, Michos ED, Ridker PM, Wang TY, Watson KE, Hutchinson HG, Nissen SE. Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory?Biomarkers. J Am Coll Cardiol. 2023 01 03; 81(1):1-12.

View in: PubMed
Desai NR, Farbaniec M, Karalis DG. Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease. Clin Cardiol. 2023 Jan; 46(1):13-21.

View in: PubMed
Rossini E, Biscetti F, Rando MM, Nardella E, Cecchini AL, Nicolazzi MA, Covino M, Gasbarrini A, Massetti M, Flex A. Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter? Int J Mol Sci. 2022 Aug 18; 23(16).

View in: PubMed
Hoshi RA, Liu Y, Luttmann-Gibson H, Tiwari S, Giulianini F, Andres AM, Watrous JD, Cook NR, Costenbader KH, Okereke OI, Ridker PM, Manson JE, Lee IM, Vinayagamoorthy M, Cheng S, Copeland T, Jain M, Chasman DI, Demler OV, Mora S. Association of Physical Activity With Bioactive Lipids and Cardiovascular Events. Circ Res. 2022 08 05; 131(4):e84-e99.

View in: PubMed
Schafer JJ, Zimmerman M, Walshe C, Cerankowski J, Shimada A, Keith SW. Weight changes in patients with sustained viral suppression switching tenofovir disoproxil fumarate to tenofovir alafenamide. Obesity (Silver Spring). 2022 Jun; 30(6):1197-1204.

View in: PubMed
Parizotto GP, de Souza LV, Thomazini F, Prado MS, Agudelo JSH, de Almeida DC, do Carmo Franco M. Birth weight and its relationship with endothelial function and pattern of endothelium-derived microparticles during childhood: New insight about early vascular damage. Life Sci. 2022 Jun 01; 298:120517.

View in: PubMed
Williams KB, Horst M, Young M, Pascua C, Puffenberger EG, Brigatti KW, Gonzaga-Jauregui C, Shuldiner AR, Gidding S, Strauss KA, Chowdhury D. Clinical characterization of familial hypercholesterolemia due to an amish founder mutation in Apolipoprotein B. BMC Cardiovasc Disord. 2022 03 17; 22(1):109.

View in: PubMed
Thomazini F, de Souza LV, Prado MS, Agudelo JSH, de Almeida DC, do Carmo Franco M. High circulating levels of CD62E+ and CD31+/Annexin V+ endothelium-derived microparticles in children with overweight/obesity: Evidence of early vascular damage. Obes Res Clin Pract. 2022 Mar-Apr; 16(2):115-121.

View in: PubMed
Block RC, Bang M, Peterson A, Wong ND, Karalis DG. Awareness, diagnosis and treatment of heterozygous familial hypercholesterolemia (HeFH) - Results of a US national survey. J Clin Lipidol. 2021 Sep-Oct; 15(5):682-689.

View in: PubMed
Hamaya R, Mora S, Lawler PR, Cook NR, Ridker PM, Buring JE, Lee IM, Manson JE, Tobias DK. Association of Plasma Branched-Chain Amino Acid With Biomarkers of Inflammation and Lipid Metabolism in Women. Circ Genom Precis Med. 2021 08; 14(4):e003330.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement